Get the Stockscreener App
2.41
3.29%
-0.082
After Hours:
2.41
Alaunos Therapeutics Inc stock is traded at $2.41, with a volume of 10,655.
It is down -3.29% in the last 24 hours and up +13.15% over the past month.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
See More
Previous Close:
$2.492
Open:
$2.5
24h Volume:
10,655
Relative Volume:
0.08
Market Cap:
$5.32M
Revenue:
-
Net Income/Loss:
$-36.46M
P/E Ratio:
-1.0042
EPS:
-2.4
Net Cash Flow:
$-30.20M
1W Performance:
-13.31%
1M Performance:
+13.15%
6M Performance:
+63.95%
1Y Performance:
-25.16%
1-Day Range:
$2.41
$2.53
1-Week Range:
$2.41
$2.85
52-Week Range:
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Name
Alaunos Therapeutics Inc
Sector
Industry
Phone
(346) 355-4099
Address
2617 BISSONNET ST, HOUSTON
Compare TCRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
2.41 | 5.50M | 0 | -36.46M | -30.20M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Resumed | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Stock (TCRT) Latest News
Why Alaunos Therapeutics Inc. stock attracts high net worth investors2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com
Is Alaunos Therapeutics Inc. stock a safe haven assetQuarterly Trade Review & Capital Efficient Trading Techniques - newser.com
Can trapped investors hope for a rebound in Alaunos Therapeutics Inc.Quarterly Market Review & Real-Time Volume Trigger Notifications - newser.com
Multi asset correlation models including Alaunos Therapeutics Inc.2025 Retail Activity & Technical Buy Zone Confirmations - newser.com
Can Alaunos Therapeutics Inc. rally from current levelsQuarterly Trade Summary & Daily Price Action Insights - newser.com
Will Alaunos Therapeutics Inc. stock gain from strong economyJuly 2025 Short Interest & Low Risk High Win Rate Picks - newser.com
Alaunos Therapeutics Inc Stock Analysis and ForecastBlue Chip Stock Analysis & Get Peace of Mind with Portfolio Health Checks - earlytimes.in
Is Alaunos Therapeutics Inc. stock supported by strong fundamentals2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
What to expect from Alaunos Therapeutics Inc. in the next 30 days2025 Market Trends & Fast Entry Momentum Trade Alerts - newser.com
Alaunos Therapeutics Inc. stock prediction for this weekFed Meeting & Real-Time Sentiment Analysis - newser.com
What analysts say about Alaunos Therapeutics Inc stockLong-Term Growth Stocks & Free Stock Market Beginner Guides - earlytimes.in
Alaunos Therapeutics Inc. stock trendline breakdownQuarterly Market Review & Precise Trade Entry Recommendations - newser.com
What drives Alaunos Therapeutics Inc stock priceStock Buyback Announcements & Big Gains Small Capital - Early Times
Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 12.3% – Should You Sell? - Defense World
Can technical indicators confirm Alaunos Therapeutics Inc.’s reversal - newser.com
Alaunos Therapeutics Inc Stock (TCRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):